Targeting tumor highly-expressed LAT1 transporter with amino acid-modified nanoparticles: Toward a novel active targeting strategy in breast cancer therapy
Authors:
- 1 April 2017
- journal article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 13 (3) , 987-998
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Nanoparticles of 2-deoxy-d-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatmentBiomaterials, 2014
- Choline transporter-targeting and co-delivery system for glioma therapyBiomaterials, 2013
- Targeted nanoparticles with novel non-peptidic ligands for oral deliveryAdvanced Drug Delivery Reviews, 2013
- Downregulation of L-type amino acid transporter 1 expression inhibits the growth, migration and invasion of gastric cancer cellsOncology Letters, 2013
- Crystal structure of a prokaryotic homologue of the mammalian oligopeptide–proton symporters, PepT1 and PepT2The EMBO Journal, 2010
- Pathways and mechanisms of endocytic recyclingNature Reviews Molecular Cell Biology, 2009
- System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell lineCancer Letters, 2009
- The Crystal Structure of a Sodium Galactose Transporter Reveals Mechanistic Insights into Na + /Sugar SymportScience, 2008
- Pharmacological Effects of Formulation VehiclesClinical Pharmacokinetics, 2003
- Cremophor ELEuropean Journal of Cancer, 2001